Carducci MA - Search Results

1

Multiple Molecular pathways explain the anti-proliferative effect of valproic acid on prostate cancer cells in vitro and in vivo.

Shabbeer S, Kortenhorst MS, Kachhap S, Galloway N, Rodriguez R, Carducci MA. Shabbeer S, et al. Among authors: carducci ma. Prostate. 2007 Jul 1;67(10):1099-110. doi: 10.1002/pros.20587. Prostate. 2007. PMID: 17477369

2

Combination of phenylbutyrate and 13-cis retinoic acid inhibits prostate tumor growth and angiogenesis.

Pili R, Kruszewski MP, Hager BW, Lantz J, Carducci MA. Pili R, et al. Among authors: carducci ma. Cancer Res. 2001 Feb 15;61(4):1477-85. Cancer Res. 2001. PMID: 11245454

3

A phase I trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy.

DeWeese TL, van der Poel H, Li S, Mikhak B, Drew R, Goemann M, Hamper U, DeJong R, Detorie N, Rodriguez R, Haulk T, DeMarzo AM, Piantadosi S, Yu DC, Chen Y, Henderson DR, Carducci MA, Nelson WG, Simons JW. DeWeese TL, et al. Among authors: carducci ma. Cancer Res. 2001 Oct 15;61(20):7464-72. Cancer Res. 2001. PMID: 11606381 Clinical Trial.

4

The design of a randomized, placebo-controlled trial of celecoxib in preprostatectomy men with clinically localized adenocarcinoma of the prostate.

Heath EI, DeWeese TL, Partin AW, De Marzo AM, Groopman JD, Nelson WG, Piantadosi SA, Lieberman R, Carducci MA. Heath EI, et al. Among authors: carducci ma. Clin Prostate Cancer. 2002 Dec;1(3):182-7. doi: 10.3816/cgc.2002.n.021. Clin Prostate Cancer. 2002. PMID: 15046694 No abstract available.

5

Early use of chemotherapy in conjunction with radical prostatectomy.

Alumkal JJ, Carducci MA. Alumkal JJ, et al. Among authors: carducci ma. Clin Prostate Cancer. 2004 Dec;3(3):144-9. doi: 10.3816/cgc.2004.n.024. Clin Prostate Cancer. 2004. PMID: 15636680 Review.

6

Focus on deacetylation for therapeutic benefit.

Shabbeer S, Carducci MA. Shabbeer S, et al. Among authors: carducci ma. IDrugs. 2005 Feb;8(2):144-54. IDrugs. 2005. PMID: 15696416 Review.

7

A phase I trial of intravenous CG7870, a replication-selective, prostate-specific antigen-targeted oncolytic adenovirus, for the treatment of hormone-refractory, metastatic prostate cancer.

Small EJ, Carducci MA, Burke JM, Rodriguez R, Fong L, van Ummersen L, Yu DC, Aimi J, Ando D, Working P, Kirn D, Wilding G. Small EJ, et al. Among authors: carducci ma. Mol Ther. 2006 Jul;14(1):107-17. doi: 10.1016/j.ymthe.2006.02.011. Epub 2006 May 9. Mol Ther. 2006. PMID: 16690359 Free article. Clinical Trial.

8

Chronic administration of valproic acid inhibits prostate cancer cell growth in vitro and in vivo.

Xia Q, Sung J, Chowdhury W, Chen CL, Höti N, Shabbeer S, Carducci M, Rodriguez R. Xia Q, et al. Cancer Res. 2006 Jul 15;66(14):7237-44. doi: 10.1158/0008-5472.CAN-05-0487. Cancer Res. 2006. PMID: 16849572

9

Class II histone deacetylases are associated with VHL-independent regulation of hypoxia-inducible factor 1 alpha.

Qian DZ, Kachhap SK, Collis SJ, Verheul HM, Carducci MA, Atadja P, Pili R. Qian DZ, et al. Among authors: carducci ma. Cancer Res. 2006 Sep 1;66(17):8814-21. doi: 10.1158/0008-5472.CAN-05-4598. Cancer Res. 2006. PMID: 16951198

10

Acetylation and histone deacetylase inhibitors in cancer.

Kortenhorst MS, Carducci MA, Shabbeer S. Kortenhorst MS, et al. Among authors: carducci ma. Cell Oncol. 2006;28(5-6):191-222. doi: 10.1155/2006/760183. Cell Oncol. 2006. PMID: 17167175 Free PMC article. Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

438 results

Search Page

Filters